GBLX
Price:
$0.0001
Market Cap:
$40.71K
GB Sciences, Inc. engages in the research and development of plant-based medicines in North America and Europe. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs. The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Sciences, Inc. in October 2016. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada.[Read more]
Industry
Biotechnology
IPO Date
2008-05-12
Stock Exchange
PNK
Ticker
GBLX
According to GB Sciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -99.64% compared to the average of -2.74 of the last 4 quarters.
The mean historical PE Ratio of GB Sciences, Inc. over the last ten years is -1.02. The current -0.01 PE Ratio has changed -2.24% with respect to the historical average. Over the past ten years (40 quarters), GBLX's PE Ratio was at its highest in in the December 2019 quarter at 1.96. The PE Ratio was at its lowest in in the March 2021 quarter at -9.09.
Average
-1.02
Median
-1.43
Minimum
-3.70
Maximum
5.39
Discovering the peaks and valleys of GB Sciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 77.40%
Maximum Annual PE Ratio = 5.39
Minimum Annual Increase = -245.69%
Minimum Annual PE Ratio = -3.70
Year | PE Ratio | Change |
---|---|---|
2024 | -1.89 | 77.40% |
2023 | -0.00 | -100.00% |
2022 | 5.39 | -245.69% |
2021 | -3.70 | 398.31% |
2020 | -0.74 | -51.59% |
2019 | -1.53 | -44.36% |
2018 | -2.75 | -4.03% |
2017 | -2.87 | 116.35% |
2016 | -1.33 | 66.04% |
2015 | -0.80 | -84.74% |
The current PE Ratio of GB Sciences, Inc. (GBLX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.16
5-year avg
-0.19
10-year avg
-1.02
GB Sciences, Inc.’s PE Ratio is greater than Biostage, Inc. (-13.23), greater than Antibe Therapeutics Inc. (-1.06), greater than Awakn Life Sciences Corp. (-1.75), greater than Tryp Therapeutics Inc. (-2.16), greater than America Great Health (-12.13), less than Theralink Technologies, Inc. (0.04), less than Adhera Therapeutics, Inc. (0), less than SciSparc Ltd. (-0.00), greater than Cellectis S.A. (-0.02), greater than Biotron Limited (-2.93), greater than Regenicin, Inc. (-4.24), less than AXIM Biotechnologies, Inc. (0), greater than Bioasis Technologies Inc. (-0.14), less than MultiCell Technologies, Inc. (0), greater than Health Sciences Group, Inc. (-0.10), less than Wesana Health Holdings Inc. (0), greater than BetterLife Pharma Inc. (-0.22), less than Covalon Technologies Ltd. (0), greater than null (-2.48), greater than null (-111.00),
Company | PE Ratio | Market cap |
---|---|---|
-13.23 | $57.82M | |
-1.06 | $11.45M | |
-1.75 | $3.95M | |
-2.16 | $5.42M | |
-12.13 | $10.59M | |
0.04 | $615.15K | |
0 | $17.33K | |
-0.00 | $2.54M | |
-0.02 | $183.12M | |
-2.93 | $11.30M | |
-4.24 | $15.35K | |
0 | $603.92K | |
-0.14 | $284.08K | |
0 | $50.01K | |
-0.10 | $187.09K | |
0 | $149.67K | |
-0.22 | $9.32M | |
0 | $72.60M | |
-2.48 | $0 | |
-111.00 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GB Sciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like GB Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is GB Sciences, Inc.'s PE Ratio?
How is the PE Ratio calculated for GB Sciences, Inc. (GBLX)?
What is the highest PE Ratio for GB Sciences, Inc. (GBLX)?
What is the 3-year average PE Ratio for GB Sciences, Inc. (GBLX)?
What is the 5-year average PE Ratio for GB Sciences, Inc. (GBLX)?
How does the current PE Ratio for GB Sciences, Inc. (GBLX) compare to its historical average?